Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis
Clinical trial NCT02260557 · COMPLETED
Trial details
- NCT number
- NCT02260557
- Sponsor
- Actelion
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-31
- Primary completion
- 2015-04-30
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.